Idoko, Olubukola T, Usuf, Effua, Okomo, Uduak, Wonodi, Chizoba, Jambo, Kondwani 
ORCID: 0000-0002-3195-2210, Kampmann, Beate, Madhi, Shabir and Adetifa, Ifedayo
(2022)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Africa: Current Considerations and Future Projections<SUP> </SUP>.
CLINICAL INFECTIOUS DISEASES, 75 (SUPPL ).
S136-S140.
|
PDF
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Africa Current Considerations and Future Projections.pdf - Open Access published version Download (489kB) | Preview |
Abstract
The burden of severe Covid-19 has been relatively low in sib-Saharan Africa compared to Europe and the Americas. However, SARS-CoV-2 sero-prevalence data has demonstrated that there has been more widespread transmission than can be deduced from reported cases. This could be attributed to under reporting due to low testing capacity or high numbers of asymptomatic SARS-CoV-2 infection in communities. Recent data indicates that prior SARS-CoV-2 exposure is protective against reinfection and that vaccination of previously SARS-CoV-2 infected individuals induces robust cross-reactive antibody responses. Considering these data, calls for a need for a re-think of the COVID-19 vaccination strategy in sub-Saharan African settings with high SARSCoV-2 population exposure but limited available vaccine doses. A potential recommendation would be to prioritize rapid and widespread vaccination of the first dose, while waiting for more vaccines to become available.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | SARS-CoV-2, Africa, burden, vaccines |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 21 Apr 2023 14:32 |
| Last Modified: | 14 Oct 2023 08:15 |
| DOI: | 10.1093/cid/ciac401 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3169867 |
Dimensions
Dimensions
